How will in silico evidence be integrated into regulatory pathways for medical technologies in Europe?
At Avicenna Days 2026, the Policy Development Working Group will bring together key stakeholders to discuss the adoption and acceptance of in silico evidence across the regulatory landscape for Medical Devices and In Vitro Diagnostic Devices.
The session will explore the European Authorities’ vision for in silico evidence in Europe, as well as the role of Notified Bodies in enabling its use across the Total Product Life Cycle of medical technologies.
Join the discussion and take part in the round table and Q&A to share perspectives on the future of digital evidence in healthcare innovation.
